Cargando…
Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis
Interest has emerged in the therapeutic potential of inhibiting store operated calcium (Ca(2+)) entry (SOCE) for melanoma and other cancers because malignant cells exhibit a strong dependence on Ca(2+) flux for disease progression. We investigated the effects of deleting Selenoprotein K (SELENOK) in...
Autores principales: | Marciel, Michael P., Khadka, Vedbar S., Deng, Youpeng, Kilicaslan, Pascal, Pham, Andrew, Bertino, Pietro, Lee, Katie, Chen, Suzie, Glibetic, Natalija, Hoffmann, FuKun W., Matter, Michelle L., Hoffmann, Peter R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862587/ https://www.ncbi.nlm.nih.gov/pubmed/29568366 http://dx.doi.org/10.18632/oncotarget.24388 |
Ejemplares similares
-
Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis
por: Marciel, Michael P., et al.
Publicado: (2018) -
Upregulated ethanolamine phospholipid synthesis via selenoprotein I is required for effective metabolic reprogramming during T cell activation
por: Ma, Chi, et al.
Publicado: (2021) -
Calpain‐2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme
por: Marciel, Michael P., et al.
Publicado: (2017) -
The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply
por: Hoffmann, Peter R., et al.
Publicado: (2007) -
Selenoprotein K Increases Efficiency of DHHC6 Catalyzed Protein Palmitoylation by Stabilizing the Acyl-DHHC6 Intermediate
por: Fredericks, Gregory J., et al.
Publicado: (2017)